| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.32 | 2e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 3e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |